Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation

mBio

Volumn 6, Issue 4, 2015, Pages

  Cowley, Elise S ^a   Kopf, Sebastian H ^b,c   Lariviere, Alejandro ^a   Ziebis, Wiebke ^d   Newman, Dianne K ^a,b,c  

^a California Institute of Technology   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; HYDROGEN SULFIDE; ION; NITROUS OXIDE; OXYCLINE; OXYGEN; SULFIDE; UNCLASSIFIED DRUG;

ANOXIA; ARTICLE; BACTERIAL INFECTION; BACTERIAL LOAD; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DEPLETION; DYNAMICS; HUMAN; MATHEMATICAL ANALYSIS; MICROBIAL GROWTH; MICROBIAL RESPIRATION; MICROENVIRONMENT; MORBIDITY; MORTALITY; MUCUS; MUCUS VOLUME; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PEDIATRICS; PH; PRESCHOOL CHILD; PRIORITY JOURNAL; SPUTUM; SURVIVAL; THICKNESS; ADOLESCENT; ANAEROBIC GROWTH; BACTERIAL PNEUMONIA; CHEMISTRY; COMPLICATION; PATHOLOGY;

ADOLESCENT; ANAEROBIOSIS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; HUMANS; HYDROGEN SULFIDE; HYDROGEN-ION CONCENTRATION; OXIDATION-REDUCTION; OXYGEN; PNEUMONIA, BACTERIAL; SPUTUM;

EID: 84940866849     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00767-15     Document Type: Article

References (92)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073. http://dx.doi.org/10.1126/science.2475911
2. Boucher RC. 2007. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58:157–170. http://dx.doi.org/10.1146/annurev.med.58.071905.105316
3. Knowles MR, Boucher RC. 2002. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109:571–577. http://dx.doi.org/10.1172/JCI15217
4. Koch C, Høiby N. 2000. Diagnosis and treatment of cystic fibrosis. Respiration 67:239–247. http://dx.doi.org/10.1159/000029503
5. Chmiel JF, Davis PB. 2003. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can’t they clear the infection? Respir Res 4:8. http://dx.doi.org/10.1186/1465-9921-4-8
6. Koch C, Høiby N. 1993. Pathogenesis of cystic fibrosis. Lancet 341: 1065–1069. http://dx.doi.org/10.1016/0140-6736(93)92422-P
7. Cystic Fibrosis Foundation. 2014. Cystic Fibrosis Foundation Patient Registry 2013 annual data report. Cystic Fibrosis Foundation, Bethesda, MD
8. Hibbing ME, Fuqua C, Parsek MR, Peterson SB. 2010. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 8:15–25. http://dx.doi.org/10.1038/nrmicro2259
9. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D’Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103:8487–8492. http://dx.doi.org/10.1073/pnas.0602138103
10. Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194–222. http://dx.doi.org/10.1128/CMR.15.2.194-222.2002
11. Jorth P, Turner KH, Gumus P, Nizam N, Buduneli N, Whiteley M. 2014. Metatranscriptomics of the human oral microbiome during health and disease. mBio 5:e01012-14. http://dx.doi.org/10.1128/mBio.01012-14
12. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109:317–325. http://dx.doi.org/10.1172/JCI13870
13. Aanaes K, Rickelt LF, Johansen HK, von Buchwald C, Pressler T, Høiby N, Jensen PØ. 2011. Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J Cyst Fibros 10:114–120. http://dx.doi.org/10.1016/j.jcf.2010.12.002
14. Kolpen M, Kühl M, Bjarnsholt T, Moser C, Hansen CR, Liengaard L, Kharazmi A, Pressler T, Høiby N, Jensen PØ. 2014. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLoS One 9:e84353. http://dx.doi.org/10.1371/journal.pone.0084353
15. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189:8079–8087. http://dx.doi.org/10.1128/JB.01138-07
16. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, Newman DK. 2012. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am J Respir Cell Mol Biol 47:738–745. http://dx.doi.org/10.1165/rcmb.2012-0088OC
17. Hunter RC, Asfour F, Dingemans J, Osuna BL, Samad T, Malfroot A, Cornelis P, Newman DK. 2013. Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. mBio 4:e00557-13. http://dx.doi.org/10.1128/mBio.00557-13
18. Tate S, MacGregor G, Davis M, Innes JA, Greening AP. 2002. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 57:926–929. http://dx.doi.org/10.1136/thorax.57.11.926
19. Newport S, Amin N, Dozor AJ. 2009. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations. Pediatr Pulmonol 44:866–872. http://dx.doi.org/10.1002/ppul.21078
20. Xu KD, Stewart PS, Xia F, Huang C-T, McFeters GA. 1998. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ Microbiol 64:4035–4039
21. Hassett DJ. 1996. Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J Bacteriol 178: 7322–7325
22. Alvarez-Ortega C, Harwood CS. 2007. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol 65:153–165. http://dx.doi.org/10.1111/j.1365-2958.2007.05772.x
23. Glasser NR, Kern SE, Newman DK. 2014. Phenazine redox cycling enhances anaerobic survival in Pseudomonas aeruginosa by facilitating generation of ATP and a proton-motive force. Mol Microbiol 92:399–412. http://dx.doi.org/10.1111/mmi.12566
24. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3:593–603. http://dx.doi.org/10.1016/S1534 -5807(02)00295-2
25. Vander Wauven C, Piérard A, Kley-Raymann M, Haas D. 1984. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J Bacteriol 160:928–934
26. Platt MD, Schurr MJ, Sauer K, Vazquez G, Kukavica-Ibrulj I, Potvin E, Levesque RC, Fedynak A, Brinkman FS, Schurr J, Hwang S-H, Lau GW, Limbach PA, Rowe JJ, Lieberman MA, Barraud N, Webb J, Kjelleberg S, Hunt DF, Hassett DJ. 2008. Proteomic, microarray, and signaturetagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J Bacteriol 190:2739–2758. http://dx.doi.org/10.1128/JB.01683-07
27. Filiatrault MJ, Wagner VE, Bushnell D, Haidaris CG, Iglewski BH, Passador L. 2005. Effect of anaerobiosis and nitrate on gene expression in Pseudomonas aeruginosa. Infect Immun 73:3764–3772. http://dx.doi.org/10.1128/IAI.73.6.3764-3772.2005
28. Van Alst NE, Picardo KF, Iglewski BH, Haidaris CG. 2007. Nitrate sensing and metabolism modulate motility, biofilm formation, and virulence in Pseudomonas aeruginosa. Infect Immun 75:3780–3790. http://dx.doi.org/10.1128/IAI.00201-07
29. Guss AM, Roeselers G, Newton IL, Young CR, Klepac-Ceraj V, Lory S, Cavanaugh CM. 2011. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J 5:20–29. http://dx.doi.org/10.1038/ismej.2010.88
30. Su S, Hassett DJ. 2012. Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or “Old Hat”? Expert Opin Ther Targets 16:859–873. http://dx.doi.org/10.1517/14728222.2012.708025
31. Quinn RA, Lim YW, Maughan H, Conrad D, Rohwer F, Whiteson KL. 2014. Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung. mBio 5:e00956-13. http://dx.doi.org/10.1128/mBio.00956-13
32. Revsbech NP, Larsen LH, Gundersen J, Dalsgaard T, Ulloa O, Thamdrup B. 2009. Determination of ultra-low oxygen concentrations in oxygen minimum zones by the STOX sensor. Limnol Oceanogr Methods 7:371–381. http://dx.doi.org/10.4319/lom.2009.7.371
33. Jeroschewski P, Steuckart C, Kühl M. 1996. An amperometric microsensor for the determination of H2S in aquatic environments. Anal Chem 68:4351–4357. http://dx.doi.org/10.1021/ac960091b
34. Kühl M, Steuckart C, Eickert G, Jeroschewski P. 1998. A H2S microsensor for profiling biofilms and sediments: application in an acidic lake sediment. Aquat Microb Ecol 15:201–209. http://dx.doi.org/10.3354/ame015201
35. Kolpen M, Kragh KN, Bjarnsholt T, Line L, Hansen CR, Dalbøge CS, Hansen N, Kühl M, Høiby N, Jensen PØ. 2015. Denitrification by cystic fibrosis pathogens—Stenotrophomonas maltophilia is dormant in sputum. Int J Med Microbiol 305:1–10. http://dx.doi.org/10.1016/j.ijmm.2014.07.002
36. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, Ciofu O, Mandsberg L, Kharazmi A, Döring G, Givskov M, Høiby N, Jensen PØ. 2010. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65:57–62. http://dx.doi.org/10.1136/thx.2009.114512
37. Babior BM, Curnutte JT, McMurrich BJ. 1976. The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. J Clin Invest 58:989–996. http://dx.doi.org/10.1172/JCI108553
38. Kempes CP, Okegbe C, Mears-Clarke Z, Follows MJ, Dietrich LE. 2014. Morphological optimization for access to dual oxidants in biofilms. Proc Natl Acad SciUSA111:208–213. http://dx.doi.org/10.1073/pnas.1315521110
39. Stressmann FA, Rogers GB, Marsh P, Lilley AK, Daniels TW, Carroll MP, Hoffman LR, Jones G, Allen CE, Patel N, Forbes B, Tuck A, Bruce KD. 2011. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J Cyst Fibros 10:357–365. http://dx.doi.org/10.1016/j.jcf.2011.05.002
40. Worthington EN, Tarran R. 2011. Methods for ASL measurements and mucus transport rates in cell cultures, p 77–92. In Amaral MD, Kunzelmann K (ed), Cystic fibrosis. Humana Press, Totowa, NJ
41. Sims DE, Horne MM. 1997. Heterogeneity of the composition and thickness of tracheal mucus in rats. Am J Physiol 273:L1036–L1041
42. Luan X, Campanucci VA, Nair M, Yilmaz O, Belev G, Machen TE, Chapman D, Ianowski JP. 2014. Pseudomonas aeruginosa triggers CFTRmediated airway surface liquid secretion in swine trachea. Proc Natl Acad Sci U S A 111:12930–12935. http://dx.doi.org/10.1073/pnas.1406414111
43. Cu Y, Saltzman WM. 2009. Mathematical modeling of molecular diffusion through mucus. Adv Drug Deliv Rev 61:101–114. http://dx.doi.org/10.1016/j.addr.2008.09.006
44. Harrison DEF. 1972. Physiological effects of dissolved oxygen tension and redox potential on growing populations of micro-organisms. J Appl Chem 22:417–440. http://dx.doi.org/10.1002/jctb.5020220311
45. Stolper DA, Revsbech NP, Canfield DE. 2010. Aerobic growth at nanomolar oxygen concentrations. Proc Natl Acad SciUSA107:18755–18760. http://dx.doi.org/10.1073/pnas.1013435107
46. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, Huttenhower C. 2012. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 8:e1002606. http://dx.doi.org/10.1371/journal.pcbi.1002606
47. Teske AP. 2012. Tracking microbial habitats in subseafloor sediments. Proc Natl Acad Sci U S A 109:16756–16757. http://dx.doi.org/10.1073/pnas.1215867109
48. Yu Z, Yang J, Amalfitano S, Yu X, Liu L. 2014. Effects of water stratifi- cation and mixing on microbial community structure in a subtropical deep reservoir. Sci Rep 4:5821. http://dx.doi.org/10.1038/srep05821
49. Stoeck T, Filker S, Edgcomb V, Orsi W, Yakimov MM, Pachiadaki M, Breiner H-W, LaCono V, Stock A. 2014. Living at the limits: evidence for microbial eukaryotes thriving under pressure in deep anoxic, hypersaline habitats. Adv Ecol 2014:532687
50. Dick GJ, Anantharaman K, Baker BJ, Li M, Reed DC, Sheik CS. 2013. The microbiology of deep-sea hydrothermal vent plumes: ecological and biogeographic linkages to seafloor and water column habitats. Front Microbiol 4:124. http://dx.doi.org/10.3389/fmicb.2013.00124
51. Stumm W, Morgan JJ. 1996. Aquatic chemistry: chemical equilibria and rates in natural waters. Wiley, New York, NY
52. de Lacy Costello BPJ, Ewen RJ, Ratcliffe NM. 2008. A sensor system for monitoring the simple gases hydrogen, carbon monoxide, hydrogen sulfide, ammonia and ethanol in exhaled breath. J Breath Res 2:037011. http://dx.doi.org/10.1088/1752-7155/2/3/037011
53. Ruiz R, Hartman TG, Karmas K, Lech J, Rosen RT. 1993. Breath analysis of garlic-borne phytochemicals in human subjects, p 102–119. In Food phytochemicals for cancer prevention I. American Chemical Society, Washington, DC
54. Pysanenko A, Španeˇl P, Smith D. 2008. A study of sulfur-containing compounds in mouth- and nose-exhaled breath and in the oral cavity using selected ion flow tube mass spectrometry. J Breath Res 2:046004. http://dx.doi.org/10.1088/1752-7155/2/4/046004
55. Wang Y, Newman DK. 2008. Redox reactions of phenazine antibiotics with ferric (hydr)oxides and molecular oxygen. Environ Sci Technol 42: 2380–2386. http://dx.doi.org/10.1021/es702290a
56. Ragsdale SW, Pierce E. 2008. Acetogenesis and the Wood-Ljungdahl pathway of CO2 fixation. Biochim Biophys Acta 1784:1873–1898. http://dx.doi.org/10.1016/j.bbapap.2008.08.012
57. Gibson GR, Cummings JH, Macfarlane GT. 1991. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Lett 86:103–111. http://dx.doi.org/10.1111/j.1574-6968.1991.tb04799.x
58. Lim YW, Schmieder R, Haynes M, Willner D, Furlan M, Youle M, Abbott K, Edwards R, Evangelista J, Conrad D, Rohwer F. 2013. Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities. J Cyst Fibros 12:154–164. http://dx.doi.org/10.1016/j.jcf.2012.07.009
59. Hampton TH, Green DM, Cutting GR, Morrison HG, Sogin ML, Gifford AH, Stanton BA, O’Toole GA. 2014. The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome 2:14. http://dx.doi.org/10.1186/2049-2618-2-14
60. Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, Sogin ML, O’Toole GA. 2013. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 1:27. http://dx.doi.org/10.1186/2049-2618-1-27
61. Hespell RB, Canale-Parola E. 1971. Amino acid and glucose fermentation by Treponema denticola. Arch Mikrobiol 78:234–251. http://dx.doi.org/10.1007/BF00424897
62. Mendes-Ferreira A, Barbosa C, Inês A, Mendes-Faia A. 2010. The timing of diammonium phosphate supplementation of wine must affects subsequent H2S release during fermentation. J Appl Microbiol 108:540–549. http://dx.doi.org/10.1111/j.1365-2672.2009.04457.x
63. Kadota H, Ishida Y. 1972. Production of volatile sulfur compounds by microorganisms. Annu Rev Microbiol 26:127–138. http://dx.doi.org/10.1146/annurev.mi.26.100172.001015
64. Kiene RP, Visscher PT. 1987. Production and fate of methylated sulfur compounds from methionine and dimethylsulfoniopropionate in anoxic salt marsh sediments. Appl Environ Microbiol 53:2426–2434
65. Shatalin K, Shatalina E, Mironov A, Nudler E. 2011. H2S: a universal defense against antibiotics in bacteria. Science 334:986–990. http://dx.doi.org/10.1126/science.1209855
66. Filkins LM, Graber JA, Olson DG, Dolben EL, Lynd LR, Bhuju S, O’Toole GA. 2015. Co-culture of Staphylococcus aureus with Pseudomonas aeruginosa drives S. aureus towards fermentative metabolism and reduced viability in a cystic fibrosis model. J Bacteriol http://dx.doi.org/10.1128/JB.00059-15
67. Behrends V, Ryall B, Zlosnik JE, Speert DP, Bundy JG, Williams HD. 2013. Metabolic adaptations of Pseudomonas aeruginosa during cystic fi- brosis chronic lung infections. Environ Microbiol 15:398–408. http://dx.doi.org/10.1111/j.1462-2920.2012.02840.x
68. Weinrick B, Dunman PM, McAleese F, Murphy E, Projan SJ, Fang Y, Novick RP. 2004. Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol 186:8407–8423. http://dx.doi.org/10.1128/JB.186.24.8407-8423.2004
69. Henry-Stanley MJ, Hess DJ, Wells CL. 2014. Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent. J Med Microbiol 63:861–869. http://dx.doi.org/10.1099/jmm.0.068130-0
70. De la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock RE. 2013. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol 16: 580–589. http://dx.doi.org/10.1016/j.mib.2013.06.013
71. Gadalla MM, Snyder SH. 2010. Hydrogen sulfide as a gasotransmitter. J Neurochem 113:14–26. http://dx.doi.org/10.1111/j.1471-4159.2010.06580.x
72. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. 2006. Hydrogen sulfide is an endogenous modulator of leukocytemediated inflammation. FASEB J 20:2118–2120. http://dx.doi.org/10.1096/fj.06-6270fje
73. Lo Faro ML, Fox B, Whatmore JL, Winyard PG, Whiteman M. 2014. Hydrogen sulfide and nitric oxide interactions in inflammation. Nitric Oxide 41:38–47. http://dx.doi.org/10.1016/j.niox.2014.05.014
74. Chen Y-H, Yao W-Z, Geng B, Ding Y-L, Lu M, Zhao M-W, Tang C-S. 2005. Endogenous hydrogen sulfide in patients with COPD. Chest 128: 3205–3211. http://dx.doi.org/10.1378/chest.128.5.3205
75. Kamboures MA, Blake DR, Cooper DM, Newcomb RL, Barker M, Larson JK, Meinardi S, Nussbaum E, Rowland FS. 2005. Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci U S A 102: 15762–15767. http://dx.doi.org/10.1073/pnas.0507263102
76. Tian M, Wang Y, Lu YQ, Yan M, Jiang YH, Zhao DY. 2012. Correlation between serum H2S and pulmonary function in children with bronchial asthma. Med Mol Rep 6:335–338. http://dx.doi.org/10.3892/mmr.2012.904
77. Chung KF. 2014. Hydrogen sulfide as a potential biomarker of asthma. Expert Rev Respir Med 8:5–13. http://dx.doi.org/10.1586/17476348.2014.856267
78. Wu CHK. 2013. The role of hydrogen sulphide in lung diseases. Biosci Horiz 6:hzt009. http://dx.doi.org/10.1093/biohorizons/hzt009
79. Garcia G. 1993. Oxygen solubility in seawater—better fitting equations (vol 37, p 1308, 1992). Limnol Oceanogr 38:656
80. Revsbech NP. 1989. An oxygen microsensor with a guard cathode. Limnol Oceanogr 34:474–478. http://dx.doi.org/10.4319/lo.1989.34.2.0474
81. Andersen K, Kjær T, Revsbech NP. 2001. An oxygen insensitive microsensor for nitrous oxide. Sens Actuators B Chem 81:42–48. http://dx.doi.org/10.1016/S0925-4005(01)00924-8
82. Thomas RC. 1979. Ion-sensitive intracellular microelectrodes: how to make and use them. Academic Press, London, United Kingdom
83. Pang H, Zhang TC. 1998. Fabrication of redox potential microelectrodes for studies in vegetated soils or biofilm systems. Environ Sci Technol 32: 3646–3652. http://dx.doi.org/10.1021/es980024u
84. Soetaert K, Meysman F. 2012. Reactive transport in aquatic ecosystems: rapid model prototyping in the open source software R. Environ Model Softw 32:49–60. http://dx.doi.org/10.1016/j.envsoft.2011.08.011
85. Soetaert K, Herman P. 2009. Using R as a simulation platform, p 372. In A practical guide to ecological modelling. Springer, Heidelberg, Germany
86. Stewart PS. 2003. Diffusion in biofilms. J Bacteriol 185:1485–1491. http://dx.doi.org/10.1128/JB.185.5.1485-1491.2003
87. Saldeña TA, Saraví FD, Hwang HJ, Cincunegui LM, Carra GE. 2000. Oxygen diffusive barriers of rat distal colon: role of subepithelial tissue, mucosa, and mucus gel layer. Dig Dis Sci 45:2108–2114. http://dx.doi.org/10.1023/A:1026411118033
88. Beyenal H, Chen SN, Lewandowski Z. 2003. The double substrate growth kinetics of Pseudomonas aeruginosa. Enzyme Microb Technol 32:92–98. http://dx.doi.org/10.1016/S0141-0229(02)00246-6
89. Morel FMM, Hering JG. 1993. Principles and applications of aquatic chemistry. John Wiley & Sons, Inc, Hoboken, NJ
90. Bujanover Y, Peled Y, Blau H, Yahav J, Katzenelson D, Gilat T. 1987. Methane production in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 6:377–380. http://dx.doi.org/10.1097/00005176-198705000-00013
91. Catalán MA, Scott-Anne K, Klein MI, Koo H, Bowen WH, Melvin JE. 2011. Elevated incidence of dental caries in a mouse model of cystic fibrosis. PLoS One 6:e16549. http://dx.doi.org/10.1371/journal.pone.0016549
92. Zmantar T, Kouidhi B, Miladi H, Mahdouani K, Bakhrouf A. 2010. A microtiter plate assay for Staphylococcus aureus biofilm quantification at various pH levels and hydrogen peroxide supplementation. New Microbiol 33:137–145.